BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang B, Liu K, Yang H, Jin Z, Ding Q, Zhao L. Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Front Cell Infect Microbiol 2022;12:855075. [DOI: 10.3389/fcimb.2022.855075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mörkl S, Butler MI, Lackner S. Advances in the gut microbiome and mood disorders. Curr Opin Psychiatry 2023;36:1-7. [PMID: 36131643 DOI: 10.1097/YCO.0000000000000829] [Reference Citation Analysis]
2 Bao Y, Han X, Liu D, Tan Z, Deng Y. Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease. Front Immunol 2022;13:1072376. [PMID: 36618372 DOI: 10.3389/fimmu.2022.1072376] [Reference Citation Analysis]
3 Huang Y, Yan S, Su Z, Xia L, Xie J, Zhang F, Du Z, Hou X, Deng J, Hao E. Aquaporins: A new target for traditional Chinese medicine in the treatment of digestive system diseases. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1069310] [Reference Citation Analysis]
4 Yuan C, Zhang W, Wang J, Huang C, Shu B, Liang Q, Huang T, Wang J, Shi Q, Tang D, Wang Y. Chinese Medicine Phenomics (Chinmedphenomics): Personalized, Precise and Promising. Phenomics 2022. [DOI: 10.1007/s43657-022-00074-x] [Reference Citation Analysis]
5 Wang YF, Li JW, Wang DP, Jin K, Hui JJ, Xu HY. Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function. Drug Des Devel Ther 2022;16:1697-711. [PMID: 35693534 DOI: 10.2147/DDDT.S360348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]